A look inside the framework: EU funding priorities and criteria in the health theme of the co-operation programme
✍ Scribed by Ruxandra Draghia-Akli
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 58 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0265-9247
No coin nor oath required. For personal study only.
✦ Synopsis
The advantages of collaborative health research
With a budget of s6.1 billion for the period 2007-2013, the Health theme of the Seventh Framework Programme for Research and Technological Development (FP7) [1,2] represents almost 19% of the EU FP7 budget for collaborative research. This provides a significant drive for the improvement of the health of both European citizens and global health and also for the competitiveness of European health related industries and businesses.
By funding transnational collaborative research projects, FP7 Health brings together excellent teams of innovative researchers from different European and associated countries as well as other international partners, working in universities, research centres, hospitals, small and medium enterprises and large industries and associations, all cooperating on ambitious objectives that would be impossible to achieve alone or in a single country.
The participants in these projects enjoy the benefits of working co-operatively in a consortium composed of partners with a complementary range of skill sets and areas of expertise. This means that they are able to tackle significantly larger objectives than would be possible if working alone, by virtue of increased financial or human resources, access to samples or infrastructures and so on. Furthermore, projects can feature partners with expertise not only in knowledge creation and research but also in knowledge exploitation and innovation. Thus, there is the opportunity for teams to develop and diversify their science and technology-based knowledge in various domains as well as the ability to undertake staff exchange and training.